Food compounds and pancreas health study
This trial looks at how certain compounds in food affect your pancreas cells and function. It is for people already enrolled in the OPCT study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already taking part in the OPCT study
- You understand what the study involves and can agree to take part
- You are not pregnant or breastfeeding
- You have not been exposed to radiation from other research before
- You do not have a history of serious mental illness or alcohol abuse
- You have not had head trauma, active nerve disease, or claustrophobia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain inflammatory or cyst-related pancreas conditions to learn more about their health and outcomes. It may help improve understanding of these pancreas problems and guide better care.
This study follows people with chronic pancreatitis to learn more about the disease and how to better diagnose it. You may have research-related scans or procedures and will be asked to stay in follow-up over time.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study uses a special blood-sugar test (a mixed meal) to better diagnose and understand diabetes related to pancreatic cancer or chronic pancreatitis, and to compare it with other diabetes types. It may help researchers find clearer ways to tell these diabetes causes apart and understand how they work.
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.